Stay updated on ImPRESS: Losartan Imaging Perfusion Clinical Trial
Sign up to get notified when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.

Latest updates to the ImPRESS: Losartan Imaging Perfusion Clinical Trial page
- CheckyesterdayChange DetectedThe page revision has been updated to v3.6.3, indicating a new edition of the study record. The change appears to be metadata-related and does not modify the study details or required actions.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of v3.6.0, signaling a new release version of the page content. This reflects an update in the page’s version rather than a substantive change to the study information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows attribution lines for Kyrre Eeg Emblem and Oslo University Hospital and adds verification-related labels. It also includes new user guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study.SummaryDifference1%

- Check29 days agoChange DetectedThe page's revision metadata was updated to v3.5.5, replacing the previous v3.5.4. This reflects a new version of the page without altering its visible content.SummaryDifference0.1%

- Check50 days agoChange DetectedAn updated site revision number is shown, changing from v3.5.3 to v3.5.4. This is a minor platform release reflected in the page metadata and does not alter the study content.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded publication citation: Lysvik EK, Tulipan AJ, Haakensen VD, Revheim MR, Emblem KE, Hjornevik T. Quantitative [18F]PSMA-1007 PET in Treatment Response Monitoring of Brain Metastases from Non-small Cell Lung Cancer. Mol Imaging Biol. 2026 Apr 23. Online ahead of print. Revision: v3.5.3.SummaryDifference0.1%

Stay in the know with updates to ImPRESS: Losartan Imaging Perfusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.